We have reported that blocking PSGL-1, PAF, or rectifying trafficking of mutated CFTR in F508del mice could lessen thrombocytopenia and alveolar neutrophil transmigration in the LPS-challenged F508del mice [2]. The gene discussed is CFTR; the disease is Thrombocytopenia.